Paper - WANFANG MED ONLINE

You Position: Home > Paper

N-乙酰半胱氨酸雾化吸入在呼吸系统疾病中的应用

( views:422, downloads:1625 )

Author:: No author available

Journal Title:: Chinese Journal of Tuberculosis and Respiratory Diseases

Issue:: 7

DOI:: 10.3760/cma.j.issn.1001-0939.2019.07.023

Key Word:: No keyword available

Abstract： N-乙酰半胱氨酸(NAC)在临床上应用广泛,具有抗氧化、清除自由基以及调节细胞代谢活性等作用,在呼吸、心血管、神经系统疾病和艾滋病的治疗上发挥了重要作用.NAC在呼吸系统疾病中的临床应用尤为广泛,具有祛痰、抗氧化、抗炎和抗生物膜等作用,对于改善呼吸系统疾病患者的临床症状和预后有积极作用.本文将NAC治疗呼吸系统疾病的作用机制及其在不同类型呼吸系统疾病的临床应用介绍如下.

Reference

[1]宋宏玲.布地奈德联合N-乙酰半胱氨酸雾化吸入治疗小儿支气管肺炎的效果观察[J].2017,(12).
[2]曲东,任晓旭,郭琳瑛,等.雾化吸入N-乙酰半胱氨酸对气管导管内生物被膜致呼吸机相关肺炎的影响[J].2016,(4).
[3]朱琳玲.吸入用乙酰半胱氨酸辅助口服莫西沙星对门诊老年糖尿病合并社区获得性肺炎患者症状评分、炎性细胞因子及免疫功能的影响[J].2017,(5).
[4]盛伟利,张永祥,尹凤先.雾化吸入N-乙酰半胱氨酸治疗急性加重期支气管扩张症临床疗效观察[J].2016,(2).
[5]马红霞,周玲,魏国烨,等.N-乙酰半胱氨酸吸入佐治小儿肺炎支原体肺炎及对免疫功能的影响[J].2017,(6).
[6]魏琳琳,段钟平.N-乙酰半胱氨酸药物作用机制实验研究进展[J].2008,(12).
[7]邬海桥,周向东.雾化吸入乙酰半胱氨酸对慢性阻塞性肺疾病急性期患者痰液的影响[J].2005,(12).
[8]张桂花,曹红谊,王静,等.ICU呼吸道感染危险因素分析[J].2001,(1).
[9]李宾,徐建刚,周向东.雾化吸入N-乙酰半胱氨酸对慢性阻塞性肺疾病急性加重期患者痰液的作用[J].2013,(12).
[10]王雯.N-乙酰半胱氨酸治疗COPD急性加重期临床疗效分析[J].2015,(8).
[11]汪宏苗,唐冬,李刚.N-乙酰半胱氨酸雾化吸入治疗老年AECOPD患者的临床观察[J].2017,(8).
[12]赵铁梅,刘又宁.N-乙酰半胱氨酸与常用抗菌药物对铜绿假单胞菌的联合抑菌作用[J].2011,(7).
[13]郭述良,吴亚梅,徐玲,等.N-乙酰半胱氨酸注射剂雾化吸入在急慢性呼吸道感染溶痰治疗中的疗效与安全性评价[J].2005,(3).
[14]魏文平,王芳,王东.N-乙酰半胱氨酸提高慢性阻塞性肺病患者运动耐量和生活质量[J].2014,(19).
[15]M, Mata,A, Ruíz,M, Cerdá,etc.Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats.[J].2003,22(6).
[16]Ryo Okuda,Hidekazu Matsushima,Tomohiro Oba,etc.Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study[J].2016,(3).
[17]Farrah, Naz,Afsheen Batool, Raza,Iftikhar, Ijaz,etc.Effectiveness of nebulized N-acetylcysteine solution in children with acute bronchiolitis.[J].2014,24(6).
[18]G S, Kelly.Clinical applications of N-acetylcysteine.[J].1998,3(2).
[19]Malcolm King.Physiology of mucus clearance[J].2006,7(Suppl.1).
[20]Rahman I,Morrison D,Donaldson K,etc.Systemic oxidative stress in asthma, COPD, and smokers.[J].1996.
[21]Animesh Kumar,Kana Ram Jat,M. Srinivas,etc.Nebulized N-Acetylcysteine for Management of Plastic Bronchitis[J].2018,55(8).
[22]黎毅敏,席寅.围手术期呼吸系统感染常见原因及治疗原则[J].2014,(2).
[23].Heparin/N-acetylcysteine: An adjuvant in the management of burn inhalation injury. A study of different doses.[J].2014,29(1).
[24]多学科围手术期气道管理中国专家共识(2018版)专家组.多学科围手术期气道管理中国专家共识（2018版）[J].2018,(7).
[25]Filewska M,Zielinski J,Demkow UA,etc.The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.[J].2005,99(2).
[26]Sakamoto, Susumu,Muramatsu, Yoko,Satoh, Keita,etc.Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study[J].2015,20(3).
[27]Hogg, James C.,Chu, Fanny,Utokaparch, Soraya,etc.The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease.[J].2004,350(26).
[28]Reinero, C. R.,Lee-Fowler, T. M.,Dodam, J. R.,etc.Endotracheal nebulization of N-acetylcysteine increases airway resistance in cats with experimental asthma.[J].2011,13(2).
[29]Frank, Antonicelli,Maryline, Parmentier,Ellen M, Drost,etc.Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells.[J].2002,32(6).
[30]Yoko Muramatsu,Keishi Sugino,Fumiaki Ishida,etc.Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis[J].2016,(3).
[31]Anna, Hart,Karnam, Sugumar,Stephen J, Milan,etc.Inhaled hyperosmolar agents for bronchiectasis.[J].2014,5.
[32].The chemistry and biological activities of N-acetylcysteine[J].2013,1830(8).
[33]D F, Rogers,P K, Jeffery.Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat.[J].1986,10(3).
[34]Kaitlin A. McGinn,Katie Weigartz,Alicia Lintner,etc.Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury[J].2017.
[35]晋荣新,鄢毅.N-乙酰半胱氨酸与盐酸氨溴索治疗小儿支气管肺炎的疗效对比及其对免疫功能和临床症状的影响[J].2018,(1).
[36]Eliasson V,Riise GC,Qvarfordt I,etc.Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro.[J].2000,67(5).
[37]Fernando J, Martinez,Harold R, Collard,Annie, Pardo,etc.Idiopathic pulmonary fibrosis.[J].2017,3(Spec ).
[38]Raghu, Ganesh,Noth, Imre,Martinez, Fernando.N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open[J].2017,5(1).
[39]NOGUERA AINA,BUSQUETS XAVIER,SAULEDA JAUME,etc.Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease[J].1998.
[40]Wu, F. -L.,Shi, T.,Sun, S. -Z.,etc.Study on JNK/AP-1 signaling pathway of airway mucus hypersecretion of severe pneumonia under RSV infection[J].2016,20(5).
[41]Giancarlo, Aldini,Alessandra, Altomare,Giovanna, Baron,etc.N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.[J].2018,(Spec ).
[42]Chang, Anne B.,Upham, John W.,Masters, I. Brent,etc.Protracted bacterial bronchitis: The last decade and the road ahead[J].2016,51(3).
[43]Xiaoyun,Li,Xiaoxia,Wei,Chaojin,Chen,etc.N-Acetylcysteine inhalation improves pulmonary function in patients received liver transplantation.[J].2018,38(5).
[44]Tugba Cosgun,Yoshito Yamada,Stephan Arni,etc.Ex?vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation[J].2017,218.
[45]Blasi, Francesco,Page, Clive,Rossolini, Gian Maria,etc.The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections[J].2016,117.
[46]Greene JJ,Hutter D.Influence of the cellular redox state on NF-kappaB-regulated gene expression.[J].2000,183(1).
[47]William MacNee.Oxidants/Antioxidants and COPD[J].2000,117(5).
[48]D F, Rogers.Mucus hypersecretion in chronic obstructive pulmonary disease.[J].2001,234.